January 18th, 2019
Alzheimer’s, the most common cause of dementia, is an irreversible brain disorder that results in memory loss, poor thinking skills, and the inability to care for oneself. It affects mostly those in their mid-60s, however, early-onset Alzheimer’s also exists. Currently, there is no cure for Alzheimer’s, however, as technology advances so do the treatment capabilities and the possibility of finding a cure in the future.
“Academics at the University of Cambridge and at Lunch University in Sweden have devised the first strategy to ‘go after’ the cause of the devastating disease which could lead to the development of new drugs to treat dementia,” says the University of Cambridge journal PNAS.
Within Alzheimer’s, nerve cells die, and loss of tissue occurs throughout the brain. Brain shrinkage occurs which destroys cells, which causes the main symptoms of Alzheimer’s. The new approach would target specific pathogens that cause Alzheimer’s which none of the existing trials have previously done. The goal is to carry out trials with this new approach by 2020.
These new trials will likely result in new treatment capabilities of Alzheimer’s resulting in the ability to reduce symptoms.